Serum IGF‐I and IGF binding proteins 2 and 3 as potential markers of doping with human GH
Andrew T. Kicman(King's College London), David Cowan(King's College London), Paul Laidler(King's College London), Peter J. Wood(James Cook University), Peter Milligan(King's College London), Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), J P Miell(King's College London), J D Teale(Royal Surrey County Hospital)
Cited by 66
Related Papers
Blood and Islet Phenotypes Indicate Immunological Heterogeneity in Type 1 Diabetes
|Diabetes|2014|244
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes
|Science Translational Medicine|2017|215
Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated β-Cell Death
|Diabetes|2011|213
Self‐monitoring in Type 2 diabetes mellitus: a meta‐analysis
|Diabetic Medicine|2000|177
Detection of growth hormone abuse in sport
|Growth Hormone & IGF Research|2007|144